The most recent findings revealed that FFAR2 is an important mediator for HDAC inhibition induced by butyrate, indicating an epigenetic tumor suppressor role for FFAR2 and blocking colon cancer progression. This evidence concerns the gene FFAR2 and malignant colon neoplasm.